{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:10:19Z","timestamp":1790975419923,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) in elderly patients has a poor prognosis. About one-third of patients have impaired perioperative performance status (PS) and often excluded from clinical trials. Brain biopsy is the standard diagnostic approach when resection is not feasible. Previous studies on preoperative prognostic factors have mostly focused on resected patients. This study aimed to identify preoperative factors associated with reduced three-month survival and treatment incompletion in elderly biopsy-only patients, with the three-month endpoint reflecting early mortality and rapid disease progression that often prevents treatment completion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed biopsy-only GBM patients aged\u2009&gt;\u200965 years between 2017 and 2020. Preoperative prognostic factors were analyzed using logistic regression, and overall survival (OS) was estimated using Kaplan\u2013Meier.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 132 patients were included. Median OS was 4.6 months, and 50% completed treatment. Palliative treatment was given to 17% of patients (median OS 1.3 months). Poor PS (OR\u2009=\u20090.2), larger tumor volume (OR\u2009=\u20090.9), and central tumor location (OR\u2009=\u20090.3) were independently associated with reduced three-month survival. Poor PS was the only predictor of treatment incompletion (OR\u2009=\u20090.06); in this subgroup, The median OS was 1.6 months, with only one of 21 completing treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In elderly patients with biopsy-only GBM, poor preoperative PS, central tumor location, and larger tumor volume were significantly associated with reduced short-term survival. Patients with poor preoperative PS were also less likely to complete treatment. These findings may aid in counseling on the potential benefits of biopsy in this vulnerable group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00701-025-06681-7","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:13:57Z","timestamp":1760138037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Factors associated with poor prognosis in elderly biopsy-only glioblastoma patients"],"prefix":"10.1007","volume":"167","author":[{"given":"Jana","family":"Edriss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Kronvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Nittby Redebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Uvelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,11]]},"reference":[{"key":"6681_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bas.2023.102742","volume":"4","author":"C Albrecht","year":"2024","unstructured":"Albrecht C, Baumgart L, Schroeder A, Wiestler B, Meyer B, Krieg SM, Ille S (2024) Impact of function-guided glioma treatment on oncological outcome in the elderly. Brain and Spine 4:102742","journal-title":"Brain and Spine"},{"issue":"12","key":"6681_CR2","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s12094-007-0142-0","volume":"9","author":"C Bala\u00f1a","year":"2007","unstructured":"Bala\u00f1a C, Capellades J, Teixidor P, Roussos I, Ballester R, Cuello M, Arellano A, Florensa R, Rosell R (2007) Clinical course of high-grade glioma patients with a \u201cbiopsy-only\u201d surgical approach: a need for individualised treatment. Clin Transl Oncol 9(12):797\u2013803","journal-title":"Clin Transl Oncol"},{"issue":"9","key":"6681_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11090909","volume":"11","author":"R Di Bonaventura","year":"2021","unstructured":"Di Bonaventura R, Montano N, Giordano M et al (2021) Reassessing the role of brain tumor biopsy in the era of advanced surgical, molecular, and imaging techniques-a single-center experience with long-term follow-up. J Pers Med 11(9):909","journal-title":"J Pers Med"},{"issue":"3","key":"6681_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3171\/2010.8.JNS1081","volume":"114","author":"KL Chaichana","year":"2011","unstructured":"Chaichana KL, Chaichana KK, Olivi A, Weingart JD, Bennett R, Brem H, Qui\u00f1ones-Hinojosa A (2011) Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival. J Neurosurg 114(3):587\u2013594","journal-title":"J Neurosurg"},{"key":"6681_CR5","unstructured":"ECOG-ACRIN Cancer Research Group. ECOG performance status [Internet]. Philadelphia (PA): ECOG-ACRIN Cancer Research Group. Available from: https:\/\/ecog-acrin.org\/resources\/ecog-performance-status\/. Accessed 15 Feb 2025"},{"key":"6681_CR6","unstructured":"Fernandes C, Costa A, Os\u00f3rio L, Lago RC, Linhares P, Carvalho B, Caeiro C (2017) Current standards of care in glioblastoma therapy. Glioblastoma"},{"issue":"1","key":"6681_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11060-017-2635-1","volume":"136","author":"L Gately","year":"2018","unstructured":"Gately L, McLachlan S-A, Philip J, Ruben J, Dowling A (2018) Long-term survivors of glioblastoma: a closer look. J Neurooncol 136(1):155\u2013162","journal-title":"J Neurooncol"},{"key":"6681_CR8","unstructured":"Glioblastoma Guidelines: Guidelines Summary. https:\/\/emedicine.medscape.com\/article\/283252-guidelines?st=fpf&scode=msp&socialSite=google&icd=login_success_gg_match_fpf&form=fpf. Accessed 18 Dec 2024"},{"issue":"10","key":"6681_CR9","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1002\/cam4.2398","volume":"8","author":"AM Glynn","year":"2019","unstructured":"Glynn AM, Rangaswamy G, O\u2019Shea J, Dunne M, Grogan R, MacNally S, Fitzpatrick D, Faul C (2019) Glioblastoma Multiforme in the over 70\u2019s: \u201cTo treat or not to treat with radiotherapy?\u201d Cancer Med 8(10):4669\u20134677","journal-title":"Cancer Med"},{"issue":"10","key":"6681_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12102327","volume":"12","author":"JM Gon\u00e7alves","year":"2024","unstructured":"Gon\u00e7alves JM, Ferreira F, Carvalho B, Pol\u00f3nia P, Linhares P (2024) Survival determinants in glioblastoma: an insight into biopsy-only patient outcomes. Biomedicines 12(10):2327","journal-title":"Biomedicines"},{"issue":"6","key":"6681_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.wneu.2011.06.014","volume":"76","author":"S Gulati","year":"2011","unstructured":"Gulati S, Jakola AS, Nerland US, Weber C, Solheim O (2011) The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma. World Neurosurg 76(6):572\u2013579","journal-title":"World Neurosurg"},{"issue":"8","key":"6681_CR12","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/neuonc\/noaa136","volume":"22","author":"A Haggiagi","year":"2020","unstructured":"Haggiagi A, Lassman AB (2020) Newly diagnosed glioblastoma in the elderly: when is temozolomide alone enough? Neuro-Oncol 22(8):1058\u20131059","journal-title":"Neuro-Oncol"},{"issue":"18","key":"6681_CR13","doi-asserted-by":"publisher","first-page":"5146","DOI":"10.1158\/1078-0432.CCR-13-0017","volume":"19","author":"C Hartmann","year":"2013","unstructured":"Hartmann C, Hentschel B, Simon M et al (2013) Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations. Clin Cancer Res 19(18):5146\u20135157","journal-title":"Clin Cancer Res"},{"key":"6681_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.05.002","volume":"189","author":"C Hertler","year":"2023","unstructured":"Hertler C, Felsberg J, Gramatzki D et al (2023) Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY brain tumor funders\u2019 collaborative consortium (EORTC 1419). Eur J Cancer 189:112913","journal-title":"Eur J Cancer"},{"key":"6681_CR15","unstructured":"Horikoshi M, Tang Y, Dickey A, Greni\u00e9 M, Thompson R, Selzer L, Strbenac D, Voronin K, Pulatov D (2024) ggfortify: data visualization tools for statistical analysis results [software]. Available from: https:\/\/CRAN.R-project.org\/package=ggfortify"},{"key":"6681_CR16","unstructured":"Ibonetti T (2024) New insights into glioblastoma treatment for older adults. Brussels: EORTC"},{"issue":"15","key":"6681_CR17","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1056\/NEJMoa065901","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert F, Chinot O, Taillandier L et al (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356(15):1527\u20131535","journal-title":"N Engl J Med"},{"issue":"15","key":"6681_CR18","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/cncr.30063","volume":"122","author":"AJ Kole","year":"2016","unstructured":"Kole AJ, Park HS, Yeboa DN, Rutter CE, Corso CD, Aneja S, Lester-Coll NH, Mancini BR, Knisely JP, Yu JB (2016) Concurrent chemoradiotherapy versus radiotherapy alone for \u201cbiopsy-only\u201d glioblastoma multiforme. Cancer 122(15):2364\u20132370","journal-title":"Cancer"},{"issue":"7","key":"6681_CR19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","volume":"21","author":"JH Lewis","year":"2003","unstructured":"Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, Housman MG, Escarce JJ (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21(7):1383\u20131389","journal-title":"J Clin Oncol"},{"key":"6681_CR20","unstructured":"Liquid Biopsy in Glioblastoma - PMC. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9323318\/. Accessed 22 Dec 2024"},{"issue":"11","key":"6681_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.clon.2017.05.010","volume":"29","author":"CF Lorimer","year":"2017","unstructured":"Lorimer CF, Hanna C, Saran F, Chalmers A, Brock J (2017) Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes. Clin Oncol R Coll Radiol GB 29(11):739\u2013747","journal-title":"Clin Oncol R Coll Radiol GB"},{"key":"6681_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/CLEP.S282475","volume":"13","author":"JF Ludvigsson","year":"2021","unstructured":"Ludvigsson JF, Appelros P, Askling J et al (2021) <p>Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden<\/p>. Clin Epidemiol 13:21\u201341","journal-title":"Clin Epidemiol"},{"issue":"1","key":"6681_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00066-003-1004-5","volume":"179","author":"J Lutterbach","year":"2003","unstructured":"Lutterbach J, Sauerbrei W, Guttenberger R (2003) Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al 179(1):8\u201315","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"6681_CR24","unstructured":"MR Anatomy of Deep Brain Nuclei with Special Reference to Specific Diseases and Deep Brain Stimulation Localization - Ryan Telford, Surjith Vattoth, 2014.\u00a0https:\/\/journals.sagepub.com\/doi\/10.15274\/NRJ-2014-10004.\u00a0Accessed 18 Dec 2024"},{"key":"6681_CR25","unstructured":"MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta\u2010analysis - Suh - 2019 - Journal of Magnetic Resonance Imaging - Wiley Online Library.\u00a0https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/jmri.26602.\u00a0Accessed 16 Mar 2025"},{"key":"6681_CR26","unstructured":"Nationellt v\u00e5rdprogram f\u00f6r tum\u00f6rer i hj\u00e4rna, ryggm\u00e4rg och dess hinnor. Stockholm: Regionalt cancercentrum (2025) Available from: https:\/\/kunskapsbanken.cancercentrum.se\/globalassets\/cancerdiagnoser\/hjarna-cns\/vardprogram\/nationellt-vardprogram-tumorer-hjarna-ryggmarg.pdf"},{"key":"6681_CR27","doi-asserted-by":"crossref","unstructured":"Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria | Neuro-Oncology | Oxford Academic. https:\/\/academic.oup.com\/neuro-oncology\/article\/19\/5\/625\/3738753. Accessed 18 Dec 2024","DOI":"10.1093\/neuonc\/nox029"},{"issue":"11","key":"6681_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ et al (2017) Short-course radiation plus temozolomide in elderly patients with glioblastoma. N Engl J Med 376(11):1027\u20131037","journal-title":"N Engl J Med"},{"issue":"3","key":"6681_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-024-04752-w","volume":"169","author":"PS Pichardo-Rojas","year":"2024","unstructured":"Pichardo-Rojas PS, Pichardo-Rojas D, Mar\u00edn-Casta\u00f1eda LA et al (2024) Prognostic value of surgical resection over biopsy in elderly patients with glioblastoma: a meta-analysis. J Neurooncol 169(3):469\u2013487","journal-title":"J Neurooncol"},{"issue":"2","key":"6681_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1093\/nop\/npac008","volume":"9","author":"J-M Pirkkalainen","year":"2022","unstructured":"Pirkkalainen J-M, J\u00e4\u00e4skel\u00e4inen A-S, Halonen P (2022) Retrospective single-center study on elderly patients with glioblastoma between 2014 and 2018 evaluating the effect of age and performance status on survival. Neuro-Oncol Pract 9(2):142\u2013148","journal-title":"Neuro-Oncol Pract"},{"key":"6681_CR31","unstructured":"R: The R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 19 Dec 2024"},{"key":"6681_CR32","unstructured":"Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply? | Neuro-Oncology Advances | Oxford Academic. https:\/\/academic.oup.com\/noa\/article\/3\/1\/vdab008\/6152004. Accessed 19 Dec 2024"},{"issue":"1","key":"6681_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10143-019-01234-w","volume":"44","author":"M Riche","year":"2021","unstructured":"Riche M, Amelot A, Peyre M, Capelle L, Carpentier A, Mathon B (2021) Complications after frame-based stereotactic brain biopsy: a systematic review. Neurosurg Rev 44(1):301\u2013307","journal-title":"Neurosurg Rev"},{"issue":"1","key":"6681_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","volume":"41","author":"L Rong","year":"2022","unstructured":"Rong L, Li N, Zhang Z (2022) Emerging therapies for glioblastoma: current state and future directions. J Exp Clin Cancer Res 41(1):142","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"6681_CR35","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","volume":"329","author":"LR Schaff","year":"2023","unstructured":"Schaff LR, Mellinghoff IK (2023) Glioblastoma and other primary brain malignancies in adults: a review. JAMA 329(7):574\u2013587","journal-title":"JAMA"},{"issue":"8","key":"6681_CR36","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00432-021-03770-9","volume":"148","author":"C Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der C, Gramatzki D, Vu E, Guckenberger M, Andratschke N, Weller M, Hertler C (2022) Radiotherapy for glioblastoma patients with poor performance status. J Cancer Res Clin Oncol 148(8):2127\u20132136","journal-title":"J Cancer Res Clin Oncol"},{"issue":"22","key":"6681_CR37","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1002\/cncr.27570","volume":"118","author":"JG Scott","year":"2012","unstructured":"Scott JG, Bauchet L, Fraum TJ et al (2012) Recursive partitioning analysis of prognostic factors for glioblastoma patients aged 70 years or older. Cancer 118(22):5595\u20135600","journal-title":"Cancer"},{"issue":"19","key":"6681_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910373","volume":"22","author":"P \u015aledzi\u0144ska","year":"2021","unstructured":"\u015aledzi\u0144ska P, Bebyn MG, Furtak J, Kowalewski J, Lewandowska MA (2021) Prognostic and predictive biomarkers in gliomas. Int J Mol Sci 22(19):10373","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6681_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10(5):459\u2013466","journal-title":"Lancet Oncol"},{"issue":"10","key":"6681_CR40","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"key":"6681_CR41","unstructured":"The 2021 World Health Organization Classification of Tumors of the Central Nervous System: What Neuroradiologists Need to Know | American Journal of Neuroradiology. https:\/\/www.ajnr.org\/content\/early\/2022\/06\/16\/ajnr.A7462\/tab-references. Accessed 18 Dec 2024"},{"key":"6681_CR42","unstructured":"Therneau T (2024) A package for survival analysis in R [software]. Available from: https:\/\/CRAN.R-project.org\/package=survival"},{"key":"6681_CR43","first-page":"7","volume":"54","author":"T Tykocki","year":"2018","unstructured":"Tykocki T, Eltayeb M (2018) Ten-year survival in glioblastoma. A systematic review. J Clin Neurosci Off J Neurosurg Soc Australas 54:7\u201313","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"6681_CR44","unstructured":"Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials | New England Journal of Medicine. https:\/\/www.nejm.org\/doi\/full\/10.1056\/nejm199912303412706?utm_source=chatgpt.com. Accessed 4 Feb 2025"},{"key":"6681_CR45","doi-asserted-by":"publisher","unstructured":"V V, S H, M F, J J (2003) Debulking or biopsy of malignant glioma in elderly people - a randomised study. Acta Neurochir (Wien). https:\/\/doi.org\/10.1007\/s00701-002-1030-6","DOI":"10.1007\/s00701-002-1030-6"},{"issue":"3","key":"6681_CR46","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","volume":"18","author":"M Weller","year":"2021","unstructured":"Weller M, van den Bent M, Preusser M et al (2021) EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 18(3):170\u2013186","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"6681_CR47","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY, Weller M, Lee EQ et al (2020) Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-oncol 22(8):1073\u20131113","journal-title":"Neuro-oncol"},{"issue":"2","key":"6681_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228480","volume":"15","author":"K Werlenius","year":"2020","unstructured":"Werlenius K, Fekete B, Blomstrand M, Car\u00e9n H, Jakola AS, Rydenhag B, Smits A (2020) Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: a population-based study of 131 consecutive patients. PLoS ONE 15(2):e0228480","journal-title":"PLoS ONE"},{"issue":"43","key":"6681_CR49","doi-asserted-by":"publisher","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J et al (2019) Welcome to the tidyverse. J Open Source Softw 4(43):1686","journal-title":"J Open Source Softw"},{"key":"6681_CR50","unstructured":"Yield and complications of frame-based and frameless stereotactic brain biopsy \u2013 The value of intra-operative histological analysis: British Journal of Neurosurgery: Vol 28 , No 5 - Get Access.\u00a0https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/02688697.2014.887657.\u00a0Accessed 18 Dec 2024"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00701-025-06681-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-025-06681-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:14:01Z","timestamp":1760138041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00701-025-06681-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6681"],"URL":"https:\/\/doi.org\/10.1007\/s00701-025-06681-7","relation":{},"ISSN":["0942-0940"],"issn-type":[{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,11]]},"assertion":[{"value":"15 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Swedish Ethical Review Authority board (Dnr 2023\u201302584-01) (Nittby Redebrandt), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. For this type of retrospective study, formal consent from individual patients was not required. A waiver of consent was granted by the Swedish Ethical Review Authority to allow the inclusion of anonymized data without introducing selection bias.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"273"}}